Skip to main content

Main menu

  • Home
  • Content
    • Current
      • JNMT Supplement
    • Ahead of print
    • Past Issues
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Permissions
    • Continuing Education
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Editorial Contact
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine Technology
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine Technology

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Permissions
    • Continuing Education
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Editorial Contact
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow SNMMI on Twitter
  • Visit SNMMI on Facebook
  • Join SNMMI on LinkedIn
  • Subscribe to JNMT RSS feeds
Review ArticleContinuing Education

Best Practices for 18F-Fluciclovine PET/CT Imaging of Recurrent Prostate Cancer: A Guide for Technologists

Funmilayo I. Tade, Rebecca A. Sajdak, Mehdat Gabriel, Robert H. Wagner and Bital Savir-Baruch
Journal of Nuclear Medicine Technology December 2019, 47 (4) 282-287; DOI: https://doi.org/10.2967/jnmt.119.227116
Funmilayo I. Tade
Division of Nuclear Medicine, Department of Radiology, Loyola University Medical Center, Maywood, Illinois
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rebecca A. Sajdak
Division of Nuclear Medicine, Department of Radiology, Loyola University Medical Center, Maywood, Illinois
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mehdat Gabriel
Division of Nuclear Medicine, Department of Radiology, Loyola University Medical Center, Maywood, Illinois
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert H. Wagner
Division of Nuclear Medicine, Department of Radiology, Loyola University Medical Center, Maywood, Illinois
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bital Savir-Baruch
Division of Nuclear Medicine, Department of Radiology, Loyola University Medical Center, Maywood, Illinois
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 47 no. 4 282-287
DOI 
https://doi.org/10.2967/jnmt.119.227116
PubMed 
31182661

Published By 
Society of Nuclear Medicine
Print ISSN 
0091-4916
Online ISSN 
1535-5675
History 
  • Received for publication February 10, 2019
  • Accepted for publication May 29, 2019
  • Published online December 4, 2019.

Article Versions

  • previous version (June 10, 2019 - 06:55).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2019 by the Society of Nuclear Medicine and Molecular Imaging.

Author Information

  1. Funmilayo I. Tade,
  2. Rebecca A. Sajdak, CNMT, RT(N), FSNMMI-TS,
  3. Mehdat Gabriel,
  4. Robert H. Wagner and
  5. Bital Savir-Baruch
  1. Division of Nuclear Medicine, Department of Radiology, Loyola University Medical Center, Maywood, Illinois
  1. For correspondence or reprints contact: Bital Savir-Baruch, Loyola University Hospital, 2160 S. First Ave., Maywood, IL 60153. E-mail: bital.savir-baruch{at}lumc.edu
View Full Text

Statistics from Altmetric.com

Cited By...

  • 5 Citations
  • 10 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • PET Imaging for Prostate Cancer
    Bital Savir-Baruch, Rudolf A. Werner, Steven P. Rowe, David M. Schuster
    Radiologic Clinics of North America 2021 59 5
  • Positivity Rate of [18F]Fluciclovine PET/CT in Patients with Suspected Prostate Cancer Recurrence at PSA Levels Below 1 ng/mL
    Jad El Bulbul, Damian Grybowski, Petra Lovrec, Abhishek A. Solanki, Medhat S. Gabriel, Robert H. Wagner, Bital Savir-Baruch
    Molecular Imaging and Biology 2022 24 1
  • Characterizing and Mitigating Bladder Radioactivity on 18F-Fluciclovine PET/CT
    Petra Lovrec, David M. Schuster, Robert H. Wagner, Medhat Gabriel, Bital Savir-Baruch
    Journal of Nuclear Medicine Technology 2020 48 1
  • Effect of hormonal therapy on 18F-fluciclovine PET/CT in the detection of prostate cancer recurrence, localization of metastatic disease, and correlation with prostate-specific antigen
    Jad El Bulbul, Abdulrahman Hashem, Damian Grybowski, Cara Joyce, Essam Rashad, Medhat S. Gabriel, Robert H. Wagner, Bital Savir-Baruch
    Urologic Oncology: Seminars and Original Investigations 2022 40 8
  • 18F-Fluciclovine
    Jason Colloton
    Journal of Nuclear Medicine Technology 2019 47 4
  • Cáncer de próstata: utilidad de 18F-fluciclovina PET/TC en la detección y diagnóstico diferencial de una metastasis ósea precoz para un tratamiento exitoso con radioterapia ablativa estereotáctica radioguiada
    T. Cassou-Mounat, S.-L. Krhili, M. Luporsi, H.-M. Amiot, V. Huchet, N. Jehanno
    Revista Española de Medicina Nuclear e Imagen Molecular 2020 39 5
  • Nuclear Medicine and Molecular Imaging
    Francesco Giammarile, Andrea Skanjeti, Rafael Hernando Reyes Marlés, Olivier Pellet
    2022
  • Prostate Cancer Imaging with 18F-Fluciclovine
    Bital Savir-Baruch, David M. Schuster
    PET Clinics 2022 17 4
  • Prostate Cancer—PET Imaging Update
    Sankarsh Jetty, James Ryan Loftus, Abhinav Patel, Akshya Gupta, Savita Puri, Vikram Dogra
    Cancers 2023 15 3
  • Prostate cancer: Usefulness of 18F-fluciclovine PET/CT in the detection and differential diagnosis of an early bone metastasis for successful treatment with radio-guided stereotactic ablative radiotherapy
    T. Cassou-Mounat, S.-L. Krhili, M. Luporsi, H.-M. Amiot, V. Huchet, N. Jehanno
    Revista Española de Medicina Nuclear e Imagen Molecular (English Edition) 2020 39 5

Article usage

Article usage: June 2019 to December 2022

AbstractFullPdf
Jun 20190054
Jul 20190041
Aug 20190024
Sep 20190031
Oct 20190023
Nov 20190021
Dec 20192872466
Jan 20202651853
Feb 20202655254
Mar 20201712833
Apr 202087839
May 2020831819
Jun 2020863324
Jul 202026105
Aug 2020441114
Sep 2020833223
Oct 2020933427
Nov 2020943719
Dec 2020381217
Jan 2021335516
Feb 2021415930
Mar 2021338919
Apr 2021288232
May 2021367323
Jun 20212312517
Jul 20212215923
Aug 20211912724
Sep 20212520523
Oct 20211618448
Nov 20212117242
Dec 20211511422
Jan 202289324
Feb 2022155411
Mar 2022119014
Apr 2022613028
May 202267628
Jun 202275310
Jul 2022115813
Aug 202266219
Sep 202296016
Oct 202297524
Nov 2022104313
Dec 202283716
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine Technology: 47 (4)
Journal of Nuclear Medicine Technology
Vol. 47, Issue 4
December 1, 2019
  • Table of Contents
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Best Practices for 18F-Fluciclovine PET/CT Imaging of Recurrent Prostate Cancer: A Guide for Technologists
(Your Name) has sent you a message from Journal of Nuclear Medicine Technology
(Your Name) thought you would like to see the Journal of Nuclear Medicine Technology web site.
Citation Tools
Best Practices for 18F-Fluciclovine PET/CT Imaging of Recurrent Prostate Cancer: A Guide for Technologists
Funmilayo I. Tade, Rebecca A. Sajdak, Mehdat Gabriel, Robert H. Wagner, Bital Savir-Baruch
Journal of Nuclear Medicine Technology Dec 2019, 47 (4) 282-287; DOI: 10.2967/jnmt.119.227116

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Best Practices for 18F-Fluciclovine PET/CT Imaging of Recurrent Prostate Cancer: A Guide for Technologists
Funmilayo I. Tade, Rebecca A. Sajdak, Mehdat Gabriel, Robert H. Wagner, Bital Savir-Baruch
Journal of Nuclear Medicine Technology Dec 2019, 47 (4) 282-287; DOI: 10.2967/jnmt.119.227116
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • PATIENT SCHEDULING
    • PATIENT PREPARATION
    • RADIOPHARMACEUTICAL INJECTION
    • PATIENT POSITIONING
    • CT ACQUISITION
    • PET ACQUISITION
    • QUALITY CONTROL
    • NORMAL BIODISTRIBUTION OF 18F-FLUCICLOVINE
    • IMAGE INTERPRETATION
    • 18F-FLUCICLOVINE PITFALLS
    • CONCLUSION
    • DISCLOSURE
    • Acknowledgments
    • APPENDIX A: BEST PRACTICES FOR 18F-FLUCICLOVINE PET/CT
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • 2019: A Year of Reflection
  • 2019: A Year of Reflection
  • Google Scholar

More in this TOC Section

  • SNMMI Clinical Trials Network Research Series for Technologists: Clinical Research Primer—Use of Imaging Agents in Therapeutic Drug Development and Approval
  • Diuretic Renal Scintigraphy Protocol Considerations
  • Root Cause Analysis in Nuclear Medicine for Sentinel Events
Show more Continuing Education

Similar Articles

Keywords

  • FACBC
  • Fluciclovine
  • PET/CT
  • prostate cancer
  • Axumin
SNMMI

© 2023 Journal of Nuclear Medicine Technology

Powered by HighWire